The French journal of urology · 2025
Long-term follow-up of AdVance™XP male sling for post-prostatectomy incontinence.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ducos Victoria, Pelette Romain, Lescure Victor, Brakbi Yannis, Beaujouan Florent, Charron Guillaume, Hammoudi Zaccharia, Chicaud Marie, Lefief Mathieu, Boudot Jules, Plainard Xavier, Descazeaud Aurélien
Аннотация
INTRODUCTION: Our objective was to evaluate the long-term efficacy of AdVance™XP male sling in the treatment of post-radical prostatectomy urinary incontinence.
METHODS: Eighty-six patients underwent male sling surgery at our center between 2010 and 2017. Data were collected in 2022 from electronic medical records, telephone interviews, standardized and validated questionnaires, including the ICIQ-SF, PGI-I, and Pad Test.
RESULTS: Among 86 patients, 16 deceased prior 2022, 16 had no efficacy at the one-month postoperative evaluation, and 4 were lost to follow-up. Adverse events occurred in 25 cases. With a median follow-up of 100 months, efficacy at the end of follow-up was observed in 41/86 (48%) patients. Among the 50 patients who had initial postoperative efficacy, 32 (64%) maintained efficacy at the end of follow-up. Loss of efficacy in the remaining 18 patients occurred with a median of 36months. Quality of life was significantly decreased in the non-effective group of patients. A history of radiotherapy, a history of operated urethral stricture, severe preoperative urinary incontinence, and age≥70years were significantly associated with the loss of efficacy in univariate analysis. In multivariate analysis, only severe preoperative urinary incontinence remained significantly associated with loss of efficacy.
CONCLUSION: With a median follow-up of 100months, efficacy at the end of follow-up was observed in almost half of all patients.
METHODS: Eighty-six patients underwent male sling surgery at our center between 2010 and 2017. Data were collected in 2022 from electronic medical records, telephone interviews, standardized and validated questionnaires, including the ICIQ-SF, PGI-I, and Pad Test.
RESULTS: Among 86 patients, 16 deceased prior 2022, 16 had no efficacy at the one-month postoperative evaluation, and 4 were lost to follow-up. Adverse events occurred in 25 cases. With a median follow-up of 100 months, efficacy at the end of follow-up was observed in 41/86 (48%) patients. Among the 50 patients who had initial postoperative efficacy, 32 (64%) maintained efficacy at the end of follow-up. Loss of efficacy in the remaining 18 patients occurred with a median of 36months. Quality of life was significantly decreased in the non-effective group of patients. A history of radiotherapy, a history of operated urethral stricture, severe preoperative urinary incontinence, and age≥70years were significantly associated with the loss of efficacy in univariate analysis. In multivariate analysis, only severe preoperative urinary incontinence remained significantly associated with loss of efficacy.
CONCLUSION: With a median follow-up of 100months, efficacy at the end of follow-up was observed in almost half of all patients.